Predictors of acute and late diarrhea in the treatment of anal cancer with concurrent chemoradiotherapy
No dosimetric or clinical predictors of late diarrhea were found and only a trend was found between higher dose to bowel and risk of acute diarrhea. Treatment with 5-FU/Capecitabine showed a notable association with acute diarrhea. No contouring method was superior in predicting diarrhea.
Authors
- Sofia Spampinato (ORCID: https://orcid.org/0000-0002-1953-7313)
- Karen‐Lise Garm Spindler (ORCID: https://orcid.org/0000-0001-8781-3212)
- Patrik Sibolt (ORCID: https://orcid.org/0000-0001-8621-7777)
- Katrine Smedegaard Storm (ORCID: https://orcid.org/0000-0002-8091-3533)
- Gitte Fredberg Persson (ORCID: https://orcid.org/0000-0002-3363-3256)
- Eva Serup‐Hansen (ORCID: https://orcid.org/0000-0001-6851-2086)
- Camilla Kronborg (ORCID: https://orcid.org/0000-0001-9783-4340)
- C.F. Behrens (ORCID: https://orcid.org/0000-0002-0686-1421)
- Sif Homburg (ORCID: https://orcid.org/0000-0001-6391-4000)
Institutions
- University of Copenhagen (DK)
- Aarhus University (DK)
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Centre for Cosmology and Particle Physics Phenomenology (DK)
- Danish Pain Research Center (DK)
- Erasmus MC Cancer Institute (NL)
- Technical University of Denmark (DK)
Publication Details
- Journal
- Acta Oncologica
- Published
- 2025-09-15
- DOI
- https://doi.org/10.2340/1651-226x.2025.43975
- Primary Topic
- Colorectal and Anal Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Aarhus Universitet
- Aarhus Universitetshospital
- Gentofte Hospital